KMT2A and acute myeloid leukemia: ZNF521 is among the top 25 genes overexpressed in AMLs with MLL fusion genes [107], in particular those expressing MLL-AF9 ([76]; Mesuraca in preparation), and is recognised as one of the prominent downstream targets of MLL-AF9 in AML cells [108].